These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34721981)

  • 1. The correlation between fibroblast growth factor-23 and ESRD patients with hearing impairment.
    Nie J; Li Q; Guo M; Li J; Yang J; Chang Q; Cai Y
    PeerJ; 2021; 9():e12295. PubMed ID: 34721981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation study of FGF23/D-serine in maintenance hemodialysis patients with combined hearing impairment.
    Yuan D; Li J; Guo M; Yang Q; Huang J; Nie J; Li R; Li Q
    PLoS One; 2023; 18(1):e0280378. PubMed ID: 36649363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of FGF23 and hearing in chronic renal failure and their correlation analysis.
    Li J; Nie J; Zhou Z; Guo M; Yang Q; Yuan D; Huang J; Li R; Li Q
    Cytokine; 2024 Feb; 174():156478. PubMed ID: 38134554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum FGF23 levels in normal and disordered phosphorus homeostasis.
    Weber TJ; Liu S; Indridason OS; Quarles LD
    J Bone Miner Res; 2003 Jul; 18(7):1227-34. PubMed ID: 12854832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of changes in FGF23 levels in childhood primary nephrotic syndrome and children who progress to end‑stage renal disease.
    Liu D; Yang F; Zhang S; Guo Z; Peng S
    Exp Ther Med; 2023 Aug; 26(2):390. PubMed ID: 37456167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
    Shardlow A; McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
    BMJ Open; 2017 Aug; 7(8):e016528. PubMed ID: 28838895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Fibroblast Growth Factor 23 Concentration: Prediction of Mortality among Chronic Kidney Disease Patients.
    Chathoth S; Al-Mueilo S; Cyrus C; Vatte C; Al-Nafaie A; Al-Ali R; Keating BJ; Al-Muhanna F; Al Ali A
    Cardiorenal Med; 2015 Dec; 6(1):73-82. PubMed ID: 27194998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on fibroblast growth factor 23 in chronic kidney disease.
    Wolf M
    Kidney Int; 2012 Oct; 82(7):737-47. PubMed ID: 22622492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
    Sánchez Fructuoso AI; Maestro ML; Pérez-Flores I; Valero R; Rafael S; Veganzones S; Calvo N; De la Orden V; De la Flor JC; Valga F; Vidaurreta M; Fernández-Pérez C; Barrientos A
    Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of associated secondary hyperparathyroidism to serum fibroblast growth factor-23 in end stage renal disease: a case-control study.
    Sliem H; Tawfik G; Moustafa F; Zaki H
    Indian J Endocrinol Metab; 2011 Apr; 15(2):105-9. PubMed ID: 21731867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of klotho gene polymorphism and the regulation of calcium-phosphate metabolism disorders in patients with end-stage renal disease.
    Zeng QY; Xia ZY; Tong YS; Sun L; Mou HB; Chen R; Bi GY; Liu CH
    Nephrology (Carlton); 2019 Oct; 24(10):1001-1008. PubMed ID: 30537427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the Relationship Between Blood Pressure and Serum FGF23 Level in Patients Undergoing Hemodialysis in Guilan Province, A Cross Sectional Study.
    Ramezanzade E; Minoo F; Lebadi MK; Jedinia A; Saheli YH; Aghajanzadeh P; Monfared A; Khosravi M
    Iran J Kidney Dis; 2019 Jul; 13(4):262-268. PubMed ID: 31422393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.
    Taal MW; Thurston V; McIntyre NJ; Fluck RJ; McIntyre CW
    Kidney Int; 2014 Aug; 86(2):407-13. PubMed ID: 24429404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease.
    Stubbs JR; He N; Idiculla A; Gillihan R; Liu S; David V; Hong Y; Quarles LD
    J Bone Miner Res; 2012 Jan; 27(1):38-46. PubMed ID: 22031097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast Growth Factor 23 Predicts Mortality and End-Stage Renal Disease in a Canadian Asian Population with Chronic Kidney Disease.
    Jialal I; Camacho F; Nathoo B; Tam P; Pahwa R; Wu GG
    Nephron; 2017; 137(3):190-196. PubMed ID: 28743129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 23 in patients undergoing peritoneal dialysis.
    Isakova T; Xie H; Barchi-Chung A; Vargas G; Sowden N; Houston J; Wahl P; Lundquist A; Epstein M; Smith K; Contreras G; Ortega L; Lenz O; Briones P; Egbert P; Ikizler TA; Jueppner H; Wolf M
    Clin J Am Soc Nephrol; 2011 Nov; 6(11):2688-95. PubMed ID: 21903990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.
    Isakova T; Wahl P; Vargas GS; Gutiérrez OM; Scialla J; Xie H; Appleby D; Nessel L; Bellovich K; Chen J; Hamm L; Gadegbeku C; Horwitz E; Townsend RR; Anderson CA; Lash JP; Hsu CY; Leonard MB; Wolf M
    Kidney Int; 2011 Jun; 79(12):1370-8. PubMed ID: 21389978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technical and diagnostic performance of a new fully automated immunoassay for the determination of intact fibroblast growth factor 23 (FGF23).
    van Helden J; Weiskirchen R
    Scand J Clin Lab Invest; 2018; 78(7-8):584-590. PubMed ID: 30380963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 23 predicts coronary calcification and poor prognosis in patients with chronic kidney disease stages 3-5D.
    Zhang M; Yan J; Zhu M; Ni Z
    Ann Clin Lab Sci; 2015; 45(1):17-22. PubMed ID: 25696005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.